Tue, January 10, 2023
Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023

Puneet Souda Maintained (ABCL) at Buy with Decreased Target to $18 on, Jan 6th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-18-on-jan-6th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $20 to $18 on, Jan 6th, 2023.

Puneet has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Puneet


  • Andrea Tan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Thursday, December 15th, 2022
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, November 16th, 2022

Publication Contributing Sources